Drug Trial Radar · NCT04137562
Safety and Efficacy in Patients With Moderate to Severe Subacute and Chronic Atopic Dermatitis
Last checked: Nov 19, 2026Latest source record: Jun 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
118
Actual
Start
Dec 11, 2019
Primary completion
Jan 26, 2023
Study completion Oct 31, 2027
Sponsor
- Lead sponsor
- EHL Bio Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Oct 24, 2019
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 19 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A Multicenter, Randomized, Single-Blind, Phase Ⅱ Clinical Trial and Open Label Long-term Observation Study of ADSTEM Inj. to Evaluate the Safety and Efficacy in Patients with Moderate to Severe Subacute and Chronic Atopic Dermatitis. The aim of this study is to evaluate the safety and efficacy of ADSTEM Inj. against Placebo in the treatment of atopic dermatitis in patients with moderate to severe acute and chronic atopic.
Conditions
- Atopic Dermatitis
Interventions
ADSTEM Inj.Biological
Two 5mL of the following study drug is pre-mixed with 320mL of 0.9% normal saline is injected intravenously twice for the duration of the study. Treatment group: ADSTEM Inj. 0.5x10\^8 cells/5mL
PlaceboOther
330mL of 0.9% normal saline is injected intravenously twice for the duration of the study.
Primary outcomes
What the sponsor says the trial is designed to measure.
- EASI-50Time frame: 16 weeks
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
Chungnam National University Hospital
Daejeon, Chungcheongnam-do, South Korea
Korea University AnSan Hospital
Ansan, Gyeonggi-do, South Korea
Chung-Ang University Hospital
Seoul, Seoulteukbyeolsi, South Korea
Kyunghee University Medical Center
Seoul, Seoulteukbyeolsi, South Korea
Seoul National University Hospital
Seoul, Seoulteukbyeolsi, South Korea
SMG-SNU Boramae Medical Center
Seoul, Seoulteukbyeolsi, South Korea
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.